LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology Read more about LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
bluebird bio to Present at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology Read more about bluebird bio to Present at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
bluebird bio Presents Updated Data from Phase 2/3 Starbeam Study of Investigational Lenti-D™ Gene Therapy for CALD and Initial Data from Observational Study ALD-103 of Allogeneic Hematopoietic Stem Cell Transplant in CALD at 2018 SSIEM Read more about bluebird bio Presents Updated Data from Phase 2/3 Starbeam Study of Investigational Lenti-D™ Gene Therapy for CALD and Initial Data from Observational Study ALD-103 of Allogeneic Hematopoietic Stem Cell Transplant in CALD at 2018 SSIEM
Morgan Stanley 16th Annual Global Healthcare Conference Read more about Morgan Stanley 16th Annual Global Healthcare Conference
bluebird bio to Present at Investor Conferences in September Read more about bluebird bio to Present at Investor Conferences in September
bluebird bio and Gritstone Oncology Announce Strategic Collaboration to Develop Novel Cancer Cell Therapies Read more about bluebird bio and Gritstone Oncology Announce Strategic Collaboration to Develop Novel Cancer Cell Therapies
Wells Fargo Securities 2018 Healthcare Conference Read more about Wells Fargo Securities 2018 Healthcare Conference
bluebird bio and Regeneron Announce Collaboration to Discover, Develop and Commercialize New Cell Therapies for Cancer Read more about bluebird bio and Regeneron Announce Collaboration to Discover, Develop and Commercialize New Cell Therapies for Cancer
bluebird bio to Present Updated Data for Lenti-D™ Gene Therapy for Cerebral Adrenoleukodystrophy at SSIEM 2018 Symposium Read more about bluebird bio to Present Updated Data for Lenti-D™ Gene Therapy for Cerebral Adrenoleukodystrophy at SSIEM 2018 Symposium